Lactoferrin Modulates Radiation Response Under Hypoxic Conditions, Possibly Through the Regulation of ROS Production in a Cell Type-Specific Manner

Lactoferrin (LF) is an iron-binding glycoprotein of the transferrin family and has been suggested to have a variety of biological functions, including anticancer activity. However, the effects of LF and its mechanisms in anticancer therapies, especially in radiotherapy against cancer cells under hyp...

Full description

Saved in:
Bibliographic Details
Main Authors: Daitoku Murakami, Takahiro Fukazawa, Michihito Kyo, Mutsumi Miyauchi, Shigehiro Ono, Tomonao Aikawa, Nobuyuki Hirohashi, Keiji Tanimoto
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/14/1/1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589351469449216
author Daitoku Murakami
Takahiro Fukazawa
Michihito Kyo
Mutsumi Miyauchi
Shigehiro Ono
Tomonao Aikawa
Nobuyuki Hirohashi
Keiji Tanimoto
author_facet Daitoku Murakami
Takahiro Fukazawa
Michihito Kyo
Mutsumi Miyauchi
Shigehiro Ono
Tomonao Aikawa
Nobuyuki Hirohashi
Keiji Tanimoto
author_sort Daitoku Murakami
collection DOAJ
description Lactoferrin (LF) is an iron-binding glycoprotein of the transferrin family and has been suggested to have a variety of biological functions, including anticancer activity. However, the effects of LF and its mechanisms in anticancer therapies, especially in radiotherapy against cancer cells under hypoxic conditions, are not well-determined. In this study, we focused on the molecular mechanisms of LF functions in cells under hypoxic conditions. High-dose LF treatment showed cytotoxic activity in a variety of cells, including both non-cancer and cancer cells. Interestingly, hypoxic treatment increased the sensitivity to LF in some cancer cells but decreased it in non-cancer cells. LF treatment also altered sensitivity to radiation treatment: LF significantly increased the viability of irradiated KD non-cancer cells under hypoxic conditions but decreased that of HSC2 cancer cells. These effects were only observed when LF was treated within 3 h of irradiation, but not before irradiation. Importantly, knockdown of <i>HIF1A</i> counteracted these effects in both cell lines. Measurements of ROS activity showed that LF decreased ROS production in KD cells but increased it in HSC2 cells, resulting in a decrease in γH2AX foci in KD cells but an increase in HSC2 cells. RNA-seq and gene set enrichment analysis showed that LF treatment regulated gene expression related to the cell cycle, apoptosis, inflammation, and the NRF2 antioxidant signaling pathway. Quantitative RT-PCR confirmed the downregulation of the pro-apoptotic gene <i>ASC</i> in KD cells and the NRF2-regulated genes in HSC2 cells by LF treatment. Knockdown experiments confirmed the role of ASC in irradiated KD cells and NRF2 in irradiated HSC2 cells with LF treatment. In conclusion, lactoferrin was shown to affect radiation treatment by regulating apoptosis and NRF2 signaling in a cell type-specific manner under hypoxic conditions, suggesting its potential application as a protector or sensitizer for radiation therapy.
format Article
id doaj-art-b7782d81685d4bafa84eba98ba1c1cbe
institution Kabale University
issn 2076-3921
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj-art-b7782d81685d4bafa84eba98ba1c1cbe2025-01-24T13:19:03ZengMDPI AGAntioxidants2076-39212024-12-01141110.3390/antiox14010001Lactoferrin Modulates Radiation Response Under Hypoxic Conditions, Possibly Through the Regulation of ROS Production in a Cell Type-Specific MannerDaitoku Murakami0Takahiro Fukazawa1Michihito Kyo2Mutsumi Miyauchi3Shigehiro Ono4Tomonao Aikawa5Nobuyuki Hirohashi6Keiji Tanimoto7Department of Radiation Disaster Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, JapanDivision of Medical Research Support, Advanced Research Support Center, Ehime University, Toon 791-0295, JapanDepartment of Radiation Disaster Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, JapanDepartment of Oral and Maxillofacial Pathobiology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, JapanDepartment of Oral and Maxillofacial Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, JapanDepartment of Oral and Maxillofacial Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, JapanDepartment of Radiation Disaster Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, JapanDepartment of Radiation Disaster Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, JapanLactoferrin (LF) is an iron-binding glycoprotein of the transferrin family and has been suggested to have a variety of biological functions, including anticancer activity. However, the effects of LF and its mechanisms in anticancer therapies, especially in radiotherapy against cancer cells under hypoxic conditions, are not well-determined. In this study, we focused on the molecular mechanisms of LF functions in cells under hypoxic conditions. High-dose LF treatment showed cytotoxic activity in a variety of cells, including both non-cancer and cancer cells. Interestingly, hypoxic treatment increased the sensitivity to LF in some cancer cells but decreased it in non-cancer cells. LF treatment also altered sensitivity to radiation treatment: LF significantly increased the viability of irradiated KD non-cancer cells under hypoxic conditions but decreased that of HSC2 cancer cells. These effects were only observed when LF was treated within 3 h of irradiation, but not before irradiation. Importantly, knockdown of <i>HIF1A</i> counteracted these effects in both cell lines. Measurements of ROS activity showed that LF decreased ROS production in KD cells but increased it in HSC2 cells, resulting in a decrease in γH2AX foci in KD cells but an increase in HSC2 cells. RNA-seq and gene set enrichment analysis showed that LF treatment regulated gene expression related to the cell cycle, apoptosis, inflammation, and the NRF2 antioxidant signaling pathway. Quantitative RT-PCR confirmed the downregulation of the pro-apoptotic gene <i>ASC</i> in KD cells and the NRF2-regulated genes in HSC2 cells by LF treatment. Knockdown experiments confirmed the role of ASC in irradiated KD cells and NRF2 in irradiated HSC2 cells with LF treatment. In conclusion, lactoferrin was shown to affect radiation treatment by regulating apoptosis and NRF2 signaling in a cell type-specific manner under hypoxic conditions, suggesting its potential application as a protector or sensitizer for radiation therapy.https://www.mdpi.com/2076-3921/14/1/1lactoferrinhypoxiaradiationreactive oxygen species (ROS)
spellingShingle Daitoku Murakami
Takahiro Fukazawa
Michihito Kyo
Mutsumi Miyauchi
Shigehiro Ono
Tomonao Aikawa
Nobuyuki Hirohashi
Keiji Tanimoto
Lactoferrin Modulates Radiation Response Under Hypoxic Conditions, Possibly Through the Regulation of ROS Production in a Cell Type-Specific Manner
Antioxidants
lactoferrin
hypoxia
radiation
reactive oxygen species (ROS)
title Lactoferrin Modulates Radiation Response Under Hypoxic Conditions, Possibly Through the Regulation of ROS Production in a Cell Type-Specific Manner
title_full Lactoferrin Modulates Radiation Response Under Hypoxic Conditions, Possibly Through the Regulation of ROS Production in a Cell Type-Specific Manner
title_fullStr Lactoferrin Modulates Radiation Response Under Hypoxic Conditions, Possibly Through the Regulation of ROS Production in a Cell Type-Specific Manner
title_full_unstemmed Lactoferrin Modulates Radiation Response Under Hypoxic Conditions, Possibly Through the Regulation of ROS Production in a Cell Type-Specific Manner
title_short Lactoferrin Modulates Radiation Response Under Hypoxic Conditions, Possibly Through the Regulation of ROS Production in a Cell Type-Specific Manner
title_sort lactoferrin modulates radiation response under hypoxic conditions possibly through the regulation of ros production in a cell type specific manner
topic lactoferrin
hypoxia
radiation
reactive oxygen species (ROS)
url https://www.mdpi.com/2076-3921/14/1/1
work_keys_str_mv AT daitokumurakami lactoferrinmodulatesradiationresponseunderhypoxicconditionspossiblythroughtheregulationofrosproductioninacelltypespecificmanner
AT takahirofukazawa lactoferrinmodulatesradiationresponseunderhypoxicconditionspossiblythroughtheregulationofrosproductioninacelltypespecificmanner
AT michihitokyo lactoferrinmodulatesradiationresponseunderhypoxicconditionspossiblythroughtheregulationofrosproductioninacelltypespecificmanner
AT mutsumimiyauchi lactoferrinmodulatesradiationresponseunderhypoxicconditionspossiblythroughtheregulationofrosproductioninacelltypespecificmanner
AT shigehiroono lactoferrinmodulatesradiationresponseunderhypoxicconditionspossiblythroughtheregulationofrosproductioninacelltypespecificmanner
AT tomonaoaikawa lactoferrinmodulatesradiationresponseunderhypoxicconditionspossiblythroughtheregulationofrosproductioninacelltypespecificmanner
AT nobuyukihirohashi lactoferrinmodulatesradiationresponseunderhypoxicconditionspossiblythroughtheregulationofrosproductioninacelltypespecificmanner
AT keijitanimoto lactoferrinmodulatesradiationresponseunderhypoxicconditionspossiblythroughtheregulationofrosproductioninacelltypespecificmanner